Bavarian Biotech Report 2011/2012 (7MB) - Bio M

medicomp GmbHCROContact:Dr. med. vet. Michael GierendFraunhoferstr. 17D-82152 MartinsriedPhone: +49 (0) 89 895286-0Fax: +49 (0) 89 895286-66E-Mail: medicomp@medicomp-cro.deInternet: www.medicomp-cro.demedicomp GmbH was founded in 1985 and has developed ever since into afull service CRO. We offer a wide range of services for phase I-IV trials, PMSand medical devices: medical and biometrical planning, protocol and CRFdesign, project management, data management, monitoring, statisticalanalysis and medical writing. medicomp is a member of the BundesverbandMedizinischer Auftragsinstitute (BVMA), which implies regular independentsystem audits. Furthermore, medicomp is a founding member ofPharmaceutical Service Network (PSN), a network of independent EuropeanCROs, which allows us to offer services for studies conducted on a Europeanscope in collaboration with our partners.MediGene AGBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Julia HofmannLochamer Str. 11D-82152 MartinsriedPhone: +49 (0) 89 856529-0Fax: +49 (0) 89 856529-20E-Mail: medigene@medigene.comInternet: www.medigene.comKeywords: Dermatology, Autoimmune Diseases, Oncology, DrugDevelopment, Immune TherapyMediGene AG is a publicly listed (Frankfurt: MDG, prime standard) biotechnologycompany headquartered in Martinsried/Munich, Germany. Medigenefocuses on clinical research and development of novel drugs against cancerand autoimmune diseases. Medigene is the first German biotech companyto have revenues from marketed products, which are distributed by partnercompanies. It has two drug candidates in clinical trials and is developing aninnovative vaccine technology.Contact:Dr. Alfred FraunhoferGmunder Str. 53D-81379 MünchenPhone: +49 (0) 89 8955718-0Fax: +49 (0) 89 8955718-100E-Mail: A.Fraunhofer@medpace.comInternet: www.medpace.deMedpace Germany GmbHCROKeywords: Monitoring, Oncology, Metabolic Diseases, CardiovascularDiseases, Clinical ResearchMedpace, established in 1992, is a full-service Contract Research Organization(CRO), who partners with leading pharmaceutical and biotech organizations tobring promising new drugs to market. Medpace combines comprehensiveregulatory consulting with efficient clinical trial management to provide sponsorswith exceptional support in drug development. Proven leaders in medicaland scientific research monitor every project. Medpace physicians have firsthandexperience working with regulatory agencies to successfully guide projectsthrough the complexities of the regulatory process. The medical expertiseand regulatory guidance provided by Medpace leads to reduced costs andincreased efficiencies for our valued customers.84